You have 9 free searches left this month | for more free features.

City

Beijing (1)

Bethesda (1)

Condition

HIV (1)

Hematologic Malignancies (1)

Moyamoya Disease (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Capital Medical University (1)

National Cancer Institute (NCI) (1)

Collaborator

Intervention

ric (2)

allo hct (1)

aspirin (1)

gvhd prophylaxis (1)

maraviroc (1)

plerixafor (1)

Study Documents

Intervention Type

drug (2)

device (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

ric

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Moyamoya Disease Trial in Beijing (RIC, Aspirin)

Completed

Moyamoya Disease

RIC
Aspirin

Beijing, Beijing, China

Xuanwu Hospital, Capital Medical University

Mar 9, 2021

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting

HIV
Hematologic Malignancies

RIC
+4 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 17, 2022